Agentix (AGTX) Stock Price, News & Analysis

Company Overview

Agentix Corp., a clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States. The company offers AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases. The company was formerly known as FairWind Energy, Inc. and changed its name to Agentix Corp. in June 2019. Agentix Corp. was founded in 2020 and is based in Dana Point, California.

Key Stats

• Today's Range: $0.05 to $0.05
• 50-Day Range: $0.03 to $0.09
• 52-Week Range: $0.02 to $0.09
• Volume: N/A
• Average Volume: 30,285 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AGTX Stock Analysis - Frequently Asked Questions

How have AGTX shares performed this year?

Agentix's stock was trading at $0.0310 on January 1st, 2024. Since then, AGTX stock has increased by 61.3% and is now trading at $0.05.
View the best growth stocks for 2024 here.

How do I buy shares of Agentix?

Shares of AGTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Agentix own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Agentix investors own include E.On (EONGY), Burcon NutraScience (BRCN), BowX Acquisition (BOWX), Bionano Genomics (BNGO), Ballard Power Systems (BLDP), BlackBerry (BB) and

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:AGTX
• CUSIP: N/A
• CIK: 1603345
• Web: fairwindenergyinc.com
• Phone: (321) 299-2014
• Fax: N/A
• Employees: 147,000
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A